Table 2. Pay out amount and funding sources in different countries with well instituted vaccine injury compensation programs.
| Country | Pay out in US dollars | Funding source | References |
|---|---|---|---|
| Denmark | Up to$100,000 | Central Taxation & Social Security | 18, 19 |
| Finland | $992,000 | Pharmaceutical Injury Insurance | 20 |
| Norway | 1.1 Million | Pharmaceutical Association | 21 |
| Sweden | $105,000 | Pharmaceutical Injury Insurance
Government Insurance |
22, 23 |
| Switzerland | No data available | Cantons, Federal Subsidies | 24 |
| Germany | No data available | General Revenue of the Lander (state governments) | 25, 26 |
| France | No data available | National Treasury | 26 |
|
United
Kingdom |
$155,000 | Public funds, National Treasury | 26, 27 |
| Italy | No data available | Ministry of Health | 28 |
| South Korea | Above $300 | Korean National Vaccine Injury Compensation Program (KNVICP) | 29, 30 |
| China | $10,400 | Government or by vaccine manufacturer | 31 |
| Japan | Up to 1 million | Class 1 - Health Service Bureau
Class 2 - Pharmaceutical and Food Safety Bureau (PFSB) |
32 |
| Taiwan | Up to 200000 | Through a 0.05 tax on each vaccine dose | 33, 34 |
| Canada (Quebec) | 4.4 Million | Provincial Ministry of Health and Social Services | 35, 36 |
| New Zealand | $2,850 average | Government funding and investment returns | 37 |
| USA | 4.7 billion to date | Through tax on each vaccine dose | 39- 41 |